{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:50:23Z","timestamp":1790139023618,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T00:00:00Z","timestamp":1436486400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s10067-015-3004-0","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T02:37:30Z","timestamp":1436409450000},"page":"1281-1286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Efficacy and safety profile of anti-interleukin-1 treatment in Beh\u00e7et\u2019s disease: a multicenter retrospective study"],"prefix":"10.1007","volume":"35","author":[{"given":"Giacomo","family":"Emmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Talarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Cimaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Cantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Goldoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Prisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Lapadula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Galeazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,10]]},"reference":[{"key":"3004_CR1","first-page":"1078","volume":"335","author":"International Study Group for Behcet disease","year":"1990","unstructured":"International Study Group for Behcet disease (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"3004_CR2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","volume":"11","author":"M Pineton de Chambrun","year":"2012","unstructured":"Pineton de Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D (2012) New insights into the pathogenesis of Beh\u00e7et\u2019s disease. Autoimmun Rev 11:687\u2013698","journal-title":"Autoimmun Rev"},{"key":"3004_CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.autrev.2014.11.009","volume":"14","author":"C Consolandi","year":"2015","unstructured":"Consolandi C, Turroni S, Emmi G, Severgnini M, Fiori J, Peano C et al (2015) Beh\u00e7et\u2019s syndrome patients exhibit specific microbiome signature. Autoimmun Rev 14:269\u2013276","journal-title":"Autoimmun Rev"},{"key":"3004_CR4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1568010053622894","volume":"4","author":"A G\u00fcl","year":"2005","unstructured":"G\u00fcl A (2005) Beh\u00e7et\u2019s disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4:81\u201383","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"3004_CR5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.gene.2013.08.026","volume":"530","author":"T Tasliyurt","year":"2013","unstructured":"Tasliyurt T, Yigit S, Rustemoglu A, Gul U, Ates O (2013) Common MEFV gene mutations in Turkish patients with Behcet\u2019s disease. Gene 530:100\u2013103","journal-title":"Gene"},{"key":"3004_CR6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/art.20873","volume":"52","author":"Z Amoura","year":"2005","unstructured":"Amoura Z, Dod\u00e9 C, Hue S, Caillat-Zucman S, Bahram S, Delpech M et al (2005) Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Beh\u00e7et\u2019s disease. Arthritis Rheum 52:608\u2013611","journal-title":"Arthritis Rheum"},{"key":"3004_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/14397595.2013.844304","volume":"24","author":"J Zou","year":"2014","unstructured":"Zou J, Guan JL (2014) Interleukin-1-related genes polymorphisms in Turkish patients with Beh\u00e7et disease: a meta-analysis. Mod Rheumatol 24:321\u2013326","journal-title":"Mod Rheumatol"},{"key":"3004_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10067-010-1566-4","volume":"30","author":"I Alexoudi","year":"2011","unstructured":"Alexoudi I, Kapsimali V, Vaiopoulos A, Kanakis M, Vaiopoulos G (2011) Evaluation of current therapeutic strategies in Beh\u00e7et\u2019s disease. Clin Rheumatol 30:157\u2013163","journal-title":"Clin Rheumatol"},{"key":"3004_CR9","doi-asserted-by":"crossref","first-page":"107421","DOI":"10.1155\/2014\/107421","volume":"2014","author":"F Caso","year":"2014","unstructured":"Caso F, Costa L, Rigante D, Lucherini OM, Caso P, Bascherini V et al (2014) Biological treatments in Beh\u00e7et\u2019s disease: beyond anti-TNF therapy. Mediators Inflamm 2014:107421","journal-title":"Mediators Inflamm"},{"key":"3004_CR10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7326\/0003-4819-149-4-200808190-00018","volume":"149","author":"C Botsios","year":"2008","unstructured":"Botsios C, Sfriso P, Furlan A, Punzi L, Dinarello CA (2008) Resistant Beh\u00e7et disease responsive to anakinra. Ann Intern Med 149:284\u2013286","journal-title":"Ann Intern Med"},{"issue":"3 Suppl 77","key":"3004_CR11","first-page":"152","volume":"31","author":"G Emmi","year":"2013","unstructured":"Emmi G, Silvestri E, Cameli AM, Bacherini D, Vannozzi L, Squatrito D et al (2013) Anakinra for resistant Beh\u00e7et uveitis: why not? Clin Exp Rheumatol 31(3 Suppl 77):152\u2013153","journal-title":"Clin Exp Rheumatol"},{"key":"3004_CR12","doi-asserted-by":"crossref","unstructured":"Cantarini L, Vitale A, Scalini P, Dinarello CA, Rigante D, Franceschini R et al (2013) Anakinra treatment in drug-resistant Beh\u00e7et\u2019s disease: a case series. Clin Rheumatol [Epub ahead of print]","DOI":"10.1007\/s10067-013-2443-8"},{"key":"3004_CR13","first-page":"S171","volume":"32","author":"F Caso","year":"2014","unstructured":"Caso F, Rigante D, Vitale A, Lucherini OM, Cantarini L (2014) Efficacy of anakinra in refractory Beh\u00e7et\u2019s disease sacroiliitis. Clin Exp Rheumatol 32:S171","journal-title":"Clin Exp Rheumatol"},{"key":"3004_CR14","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1136\/annrheumdis-2012-201383","volume":"71","author":"S Ugurlu","year":"2012","unstructured":"Ugurlu S, Ucar D, Seyahi E, Hatemi G, Yurdakul S (2012) Canakinumab in a patient with juvenile Behcet\u2019s syndrome with refractory eye disease. Ann Rheum Dis 71:1589\u20131591","journal-title":"Ann Rheum Dis"},{"key":"3004_CR15","first-page":"S115","volume":"30","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Vitale A, Borri M, Galeazzi M, Franceschini R (2012) Successful use of canakinumab in a patient with resistant Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 30:S115","journal-title":"Clin Exp Rheumatol"},{"key":"3004_CR16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000358125","volume":"228","author":"A Vitale","year":"2014","unstructured":"Vitale A, Rigante D, Caso F, Brizi MG, Galeazzi M, Costa L et al (2014) Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Beh\u00e7et\u2019s disease: a case series. Dermatology 228:211\u2013214","journal-title":"Dermatology"},{"issue":"4 Suppl 84","key":"3004_CR17","first-page":"S172","volume":"32","author":"G Emmi","year":"2014","unstructured":"Emmi G, Silvestri E, Ciucciarelli L, Squatrito D, Emmi L (2014) Reply: anti-IL1 blocking agents in drug-resistant Beh\u00e7et\u2019s syndrome: our little case series. Clin Exp Rheumatol 32(4 Suppl 84):S172","journal-title":"Clin Exp Rheumatol"},{"key":"3004_CR18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/annrheumdis-2011-155143","volume":"71","author":"A G\u00fcl","year":"2012","unstructured":"G\u00fcl A, Tugal-Tutkun I, Dinarello CA, Reznikov L, Esen BA, Mirza A et al (2012) Interleukin-1\u03b2-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet\u2019s disease: an open-label pilot study. Ann Rheum Dis 71:563\u2013566","journal-title":"Ann Rheum Dis"},{"key":"3004_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2014.08.008","volume":"14","author":"L Cantarini","year":"2015","unstructured":"Cantarini L, Lopalco G, Caso F, Costa L, Iannone F, Lapadula G et al (2015) Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Beh\u00e7et\u2019s disease. Autoimmun Rev 14:1\u20139","journal-title":"Autoimmun Rev"},{"key":"3004_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3899\/jrheum.140102","volume":"91","author":"F Cantini","year":"2014","unstructured":"Cantini F, Niccoli L, Goletti D (2014) Adalimumab, etanercept, infliximab, and the risk of tuberculosis: data from clinical trials, national registries, and postmarketing surveillance. J Rheumatol Suppl 91:47\u201355","journal-title":"J Rheumatol Suppl"},{"key":"3004_CR21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.autrev.2004.09.001","volume":"4","author":"C Botsios","year":"2005","unstructured":"Botsios C (2005) Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases. Autoimmun Rev 4:162\u2013170","journal-title":"Autoimmun Rev"},{"key":"3004_CR22","author":"I Pagnini","year":"2015","unstructured":"Pagnini I, Bondi T, Simonini G, Giani T, Marino A, Cimaz R (2015) Successful treatment with canakinumab of a paediatric patient with resistant Behcet\u2019s disease. Rheumatology. doi: 10.1093\/rheumatology\/kev197","journal-title":"Rheumatology"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-3004-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-3004-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-3004-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T03:11:51Z","timestamp":1566961911000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-3004-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,10]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["3004"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-3004-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,10]]}}}